Holen Sie sich die Stockscreener-App
5.90
0.34%
0.02
Handel nachbörslich:
5.90
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy? - TradingView
Published on: 2026-03-12 08:35:52 - baoquankhu1.vn
Puma Biotech (PBYI) Earnings Call Transcript - AOL.com
Puma Biotechnology (NASDAQ:PBYI) Upgraded at Wall Street Zen - MarketBeat
PBYI Q4 earnings & sales beat estimates, stock down on weak 2026 view - MSN
Puma Biotech at TD Cowen Conference: Strategic Growth and Financial Discipline - Investing.com Canada
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2025 Earnings Call Transcript - Insider Monkey
PBYI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Puma Biotechnology (PBYI) Margin Resilience Tests Bearish Earnings Forecasts In FY 2025 Results - Sahm
Puma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by Wall Street Zen - MarketBeat
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View - The Globe and Mail
PBYI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Puma Biotechnology, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PBYI) 2026-02-27 - Seeking Alpha
Earnings call transcript: Puma Biotechnology Q4 2025 beats forecasts with strong revenue growth - Investing.com India
Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace
Puma Biotechnology Q4 Earnings Call Highlights - MarketBeat
Puma Biotechnology (NASDAQ:PBYI) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Puma Biotechnology Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Puma Biotech: Fourth Quarter Earnings Overview - Bitget
Puma Biotechnology (PBYI) Releases Q4 2025 Earnings: Revenue Beats, EPS Tops Estimates but Cash Falls - Quiver Quantitative
Puma Biotechnology Q4 Earnings Report: What Investors Need to Know - Benzinga
Puma Biotechnology Hits New 52-Week High of $7.68, Up 120% - Markets Mojo
Puma Biotechnology Inc expected to post earnings of 23 cents a shareEarnings Preview - TradingView
Analyst Downgrade: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Trend Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference - BioSpace
Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference - lelezard.com
Dip Buying: Whats the profit margin of BBDCJuly 2025 Price Swings & AI Driven Price Forecasts - baoquankhu1.vn
Puma Biotech (PBYI) CFO awarded new RSU and option grants - Stock Titan
Will Puma Biotechnology Inc. stock maintain dividend yieldWeekly Earnings Recap & AI Enhanced Market Trend Forecasts - mfd.ru
PUMA Biotechnology (PBYI) CEO awarded new stock options and RSUs - Stock Titan
Layoff Watch: Can Puma Biotechnology Inc be the next market leaderTrade Ideas & Real-Time Sentiment Analysis - baoquankhu1.vn
Published on: 2026-02-19 23:57:17 - baoquankhu1.vn
Naya Capital Adds Masimo Shares - AOL.com
Puma Biotechnology (PBYI) to Release Earnings on Thursday - MarketBeat
Puma Biotechnology (NASDAQ:PBYI) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - BioSpace
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Re - pharmiweb.com
Puma Biotechnology sets Feb. 26 call on 2025 financial results - Stock Titan
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Yahoo Finance
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Why Puma Biotechnology Inc. stock is popular among millennials2025 Volume Leaders & Risk Controlled Daily Trade Plans - mfd.ru
Fund Flows: Is Puma Biotechnology Inc undervalued by DCF analysisTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 4, 2026 - BioSpace
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule - TradingView
Puma Biotechnology (PBYI) Price Target Increased by 42.86% to 5.10 - Nasdaq
Is Puma Biotechnology Inc. stock a defensive play in 2025Quarterly Performance Summary & Real-Time Chart Pattern Alerts - mfd.ru
Investor Mood: How does Puma Biotechnology Inc. compare to its peersRisk Management & Risk Controlled Stock Alerts - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Buys 159,200 Shares of Puma Biotechnology, Inc. $PBYI - MarketBeat
Revenue Check: Is Puma Biotechnology Inc. stock suitable for long term investing - mfd.ru
Hedge Fund Bets: Is FONAR Corporation exposed to currency risks2025 Technical Patterns & Consistent Return Strategy Ideas - baoquankhu1.vn
Surprises Report: Will Puma Biotechnology Inc benefit from rate cutsJuly 2025 Action & Verified Short-Term Plans - baoquankhu1.vn
Should You Buy Alnylam Pharmaceuticals Before Feb. 12? - AOL.com
Momentum Shift: Can CALC maintain sales growthEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):